Amprius Technologies (NYSE:AMPX) Director Kang Sun Sells 506,267 Shares

Key Points

• Director Kang Sun sold 506,267 shares on Jan. 12 at an average of $10.10 for about $5.11M, leaving him with 1,403,651 shares (a 26.51% reduction); combined with two November sales he’s disposed of roughly 1.575M shares for about $16.4M in proceeds.
• AMPX traded near $10.35 (12‑month range $1.70–$16.03) with a $1.35B market cap; the company posted a revenue beat but negative EPS, and analysts’ consensus is a Moderate Buy with an average price target of $14.57.

Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report) Director Kang Sun sold 506,267 shares of Amprius Technologies stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $10.10, for a total value of $5,113,296.70. Following the completion of the transaction, the director owned 1,403,651 shares in the company, valued at $14,176,875.10. This trade represents a 26.51% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Kang Sun also recently made the following trade(s):

• On Friday, November 21st, Kang Sun sold 68,655 shares of Amprius Technologies stock. The shares were sold at an average price of $10.08, for a total transaction of $692,042.40.
• On Monday, November 17th, Kang Sun sold 1,000,000 shares of Amprius Technologies stock. The stock was sold at an average price of $10.60, for a total transaction of $10,600,000.00.

Amprius Technologies Stock Performance

NYSE:AMPX traded up $0.68 during midday trading on Wednesday, reaching $10.35. 6,783,360 shares of the stock traded hands, compared to its average volume of 6,765,895. Amprius Technologies, Inc. has a 12-month low of $1.70 and a 12-month high of $16.03. The business has a 50-day moving average of $10.28 and a two-hundred day moving average of $9.53. The stock has a market capitalization of $1.35 billion, a PE ratio of -39.81 and a beta of 3.04.

Amprius Technologies (NYSE:AMPX - Get Free Report) last issued its quarterly earnings results on Thursday, November 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.06) by $0.03. Amprius Technologies had a negative return on equity of 38.85% and a negative net margin of 53.16%.The business had revenue of $21.43 million for the quarter, compared to the consensus estimate of $16.45 million. Research analysts anticipate that Amprius Technologies, Inc. will post -0.45 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in AMPX. Vanguard Group Inc. raised its position in shares of Amprius Technologies by 37.0% in the third quarter. Vanguard Group Inc. now owns 6,512,620 shares of the company's stock valued at $68,513,000 after buying an additional 1,757,395 shares during the last quarter. Invesco Ltd. lifted its stake in Amprius Technologies by 113.3% in the 3rd quarter. Invesco Ltd. now owns 2,379,384 shares of the company's stock worth $25,031,000 after purchasing an additional 1,263,846 shares in the last quarter. BNP Paribas Financial Markets boosted its holdings in shares of Amprius Technologies by 1,117.9% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,943,905 shares of the company's stock worth $20,450,000 after purchasing an additional 1,784,291 shares during the last quarter. Voloridge Investment Management LLC purchased a new stake in shares of Amprius Technologies in the third quarter valued at approximately $19,737,000. Finally, Two Sigma Investments LP increased its holdings in shares of Amprius Technologies by 24.2% in the third quarter. Two Sigma Investments LP now owns 1,753,577 shares of the company's stock valued at $18,448,000 after purchasing an additional 341,969 shares during the last quarter. Hedge funds and other institutional investors own 5.04% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. Roth Capital set a $14.00 price target on shares of Amprius Technologies and gave the company a "buy" rating in a research note on Wednesday, October 22nd. Northland Securities set a $20.00 target price on Amprius Technologies in a research report on Tuesday, October 7th. Oppenheimer reaffirmed an "outperform" rating and set a $17.00 price target on shares of Amprius Technologies in a research report on Tuesday, December 23rd. Weiss Ratings reiterated a "sell (e+)" rating on shares of Amprius Technologies in a report on Wednesday, October 8th. Finally, Cantor Fitzgerald raised their target price on shares of Amprius Technologies from $12.00 to $16.00 and gave the stock an "overweight" rating in a report on Friday, November 7th. Seven analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $14.57.

About Amprius Technologies

Amprius Technologies, Inc NYSE: AMPX is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.